The preparation of ilexgenin A possessed an inhibitory effect on the expression of dynamin 1-related protein (DRP1), which is a regulator of mitochondrial fission, that can reduce the production of ROS and inflammatory mediators, and also improve endothelial dysfunction, thereby preventing atherogenesis [64]. This evidence concerns the gene DNM1L and endothelial dysfunction.